HFCAS OpenIR

浏览/检索结果: 共5条,第1-5条 帮助

已选(0)清除 条数/页:   排序方式:
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor 期刊论文
THORACIC CANCER, 2022
作者:  Wang, Wenxian;  Wang, Qian;  Xu, Chunwei;  Li, Ziming;  Song, Zhengbo;  Zhang, Yongchang;  Cai, Xiuyu;  Zhang, Shirong;  Lian, Bin;  Li, Wen;  Liu, Anwen;  Zhan, Ping;  Liu, Hongbing;  Lv, Tangfeng;  Miao, Liyun;  Min, Lingfeng;  Chen, Yu;  Yuan, Jingping;  Wang, Feng;  Jiang, Zhansheng;  Lin, Gen;  Pu, Xingxiang;  Rao, Chuangzhou;  Lv, Dongqing;  Yu, Zongyang;  Li, Xiaoyan;  Tang, Chuanhao;  Zhou, Chengzhi;  Xie, Congying;  Zhang, Junping;  Guo, Hui;  Chu, Qian;  Meng, Rui;  Wu, Jingxun;  Zhang, Rui;  Wang, Liping;  Zhu, Youcai;  Hu, Xiao;  Xie, Yanru;  Lin, Xinqing;  Cai, Jing;  Lan, Fen;  Feng, Huijing;  Wang, Lin;  Yao, Wang;  Shi, Xuefei;  Huang, Jianhui;  Chen, Huafei;  Zhang, Yinbin;  Sun, Pingli;  Wan, Bing;  Pang, Fei;  Xu, Zanmei;  Wang, Kai;  Xia, Yuanli;  Ye, Mingxiang;  Wang, Dong;  Wei, Qing;  Feng, Shuitu;  Zhou, Jianya;  Zhang, Jiexia;  Lv, Donglai;  Gao, Wenbin;  Kang, Jing;  Yu, Genhua;  Liang, Xianbin;  Yu, Chengtao;  Shi, Lin;  Yang, Nong;  Wu, Lin;  Hong, Zhuan;  Hong, Wei;  Fang, Meiyu;  Zhang, Yiping;  Lu, Yuanzhi;  Wang, Guansong;  Ma, Shenglin;  Si, Lu;  Fang, Wenfeng;  Song, Yong
收藏  |  浏览/下载:43/0  |  提交时间:2022/12/23
checkpoint inhibitor pneumonitis  Chinese experts consensus  immune checkpoint inhibitor-related adverse effects  
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China 期刊论文
THORACIC CANCER, 2022
作者:  Xu, Chunwei;  Si, Lu;  Wang, Wenxian;  Li, Ziming;  Song, Zhengbo;  Wang, Qian;  Liu, Aijun;  Yu, Jinpu;  Fang, Wenfeng;  Zhong, Wenzhao;  Wang, Zhijie;  Zhang, Yongchang;  Liu, Jingjing;  Zhang, Shirong;  Cai, Xiuyu;  Liu, Anwen;  Li, Wen;  Zhan, Ping;  Liu, Hongbing;  Lv, Tangfeng;  Miao, Liyun;  Min, Lingfeng;  Chen, Yu;  Yuan, Jingping;  Wang, Feng;  Jiang, Zhansheng;  Lin, Gen;  Pu, Xingxiang;  Lin, Rongbo;  Liu, Weifeng;  Rao, Chuangzhou;  Lv, Dongqing;  Yu, Zongyang;  Lei, Lei;  Li, Xiaoyan;  Tang, Chuanhao;  Zhou, Chengzhi;  Zhang, Junping;  Xue, Junli;  Guo, Hui;  Chu, Qian;  Meng, Rui;  Wu, Jingxun;  Zhang, Rui;  Hu, Xiao;  Zhou, Jin;  Zhu, Zhengfei;  Li, Yongheng;  Qiu, Hong;  Xia, Fan;  Lu, Yuanyuan;  Chen, Xiaofeng;  Ge, Rui;  Dai, Enyong;  Han, Yu;  Pan, Weiwei;  Luo, Jiancheng;  Jia, Hongtao;  Dong, Xiaowei;  Pang, Fei;  Wang, Kai;  Wang, Liping;  Zhu, Youcai;  Xie, Yanru;  Lin, Xinqin;  Cai, Jing;  Wei, Jia;  Lan, Fen;  Feng, Huijing;  Wang, Lin;  Du, Yingying;  Yao, Wang;  Shi, Xuefei;  Niu, Xiaomin;  Yuan, Dongmei;  Yao, Yanwen;  Huang, Jianhui;  Zhang, Yinbin;  Sun, Pingli;  Wang, Hong;  Ye, Mingxiang;  Wang, Dong;  Wang, Zhaofeng;  Wan, Bing;  Lv, Donglai;  Wei, Qing;  Kang, Jin;  Zhang, Jiatao;  Zhang, Chao;  Yu, Genhua;  Ou, Juanjuan;  Shi, Lin;  Li, Zhongwu;  Liu, Zhefeng;  Liu, Jing;  Yang, Nong;  Wu, Lin;  Wang, Huijuan;  Jin, Gu;  Yang, Liu;  Wang, Guansong;  Fang, Meiyu;  Fang, Yong;  Li, Yuan;  Wang, Xiaojia;  Zhang, Yiping;  Ma, Shenglin;  Wang, Biyun;  Zhang, Xiaotian;  Song, Yong;  Lu, Yuanzhi
收藏  |  浏览/下载:44/0  |  提交时间:2022/12/22
fusion  precision medicine  solid tumor  targeted therapy  tyrosine receptor kinase  
Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial 期刊论文
LANCET ONCOLOGY, 2022, 卷号: 23
作者:  Zhou, Qing;  Chen, Ming;  Jiang, Ou;  Pan, Yi;  Hu, Desheng;  Lin, Qin;  Wu, Gang;  Cui, Jiuwei;  Chang, Jianhua;  Cheng, Yufeng;  Huang, Cheng;  Liu, Anwen;  Yang, Nong;  Gong, Youling;  Zhu, Chuan;  Ma, Zhiyong;  Fang, Jian;  Chen, Gongyan;  Zhao, Jun;  Shi, Anhui;  Lin, Yingcheng;  Li, Guanghui;  Liu, Yunpeng;  Wang, Dong;  Wu, Rong;  Xu, Xinhua;  Shi, Jianhua;  Liu, Zhihua;  Cui, Na;  Wang, Jingru;  Wang, Qiang;  Zhang, Ran;  Yang, Jason;  Wu, Yi-Long
收藏  |  浏览/下载:71/0  |  提交时间:2022/03/21
Immune checkpoint inhibitor-related adverse events in lung cancer: Real-world incidence and management practices of 1905 patients in China 期刊论文
THORACIC CANCER, 2021
作者:  Shi, Yuequan;  Fang, Jian;  Zhou, Chengzhi;  Liu, Anwen;  Wang, Yan;  Meng, Qingwei;  Ding, Cuimin;  Ai, Bin;  Gu, Yangchun;  Yao, Yu;  Sun, Hong;  Guo, Hui;  Zhang, Cuiying;  Song, Xia;  Li, Junling;  Xu, Bei;  Han, Zhiqiang;  Song, Meijun;  Tang, Tingyu;  Chen, Peifeng;  Lu, Hongmin;  Shui, Yongjie;  Lou, Guangyuan;  Zhang, Dongming;  Liu, Jia;  Liu, Xiaoyan;  Liu, Xiangning;  Gao, Xiaoxing;  Zhou, Qing;  Chen, Minjiang;  Zhao, Jing;  Zhong, Wei;  Xu, Yan;  Wang, Mengzhao
收藏  |  浏览/下载:81/0  |  提交时间:2022/01/25
advanced lung cancer  immune checkpoint inhibitors  immune-related adverse events  real-world data  
~(13)CH_4分子v_3振动带空气和氮气加宽系数温度依赖性研究 期刊论文
物理学报, 2015, 卷号: 64
作者:  马宏亮;  孙明国;  刘安雯;  Aurore Vicet;  陈卫东;  曹振松;  王贵师;  刘强;  高晓明;  饶瑞中
收藏  |  浏览/下载:38/0  |  提交时间:2020/11/25
红外光谱  碰撞加宽系数  温度依赖系数